Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Antibodies, Monoclonal therapeutic use"" wg kryterium: Temat


Tytuł :
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.
Autorzy :
Hirano, I.
Collins, M.H.
Assouline-Dayan, Y.
Evans, L.
Gupta, S.
Schoepfer, A.M.
Straumann, A.
Safroneeva, E.
Grimm, M.
Smith, H.
Tompkins, C.A.
Woo, A.
Peach, R.
Frohna, P.
Gujrathi, S.
Penenberg, D.N.
Li, C.
Opiteck, G.J.
Olson, A.
Aranda, R.
Rothenberg, M.E.
Dellon, E.S.
Pokaż więcej
Temat :
Antibodies, Monoclonal/therapeutic use
Antibodies, Monoclonal, Humanized/therapeutic use
Biopsy, Needle
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Eosinophilic Esophagitis/diagnosis
Eosinophilic Esophagitis/drug therapy
Eosinophilic Esophagitis/pathology
Esophagoscopy/methods
Female
Humans
Immunohistochemistry
Interleukin-13/immunology
Internationality
Male
Patient Safety
Reference Values
Severity of Illness Index
Treatment Outcome
Esophagus
Immune Response
Placebo-Controlled
Randomized
610 Medicine & health
360 Social problems & social services
Źródło :
Hirano, Ikuo; Collins, Margaret H; Assouline-Dayan, Yehudith; Evans, Larry; Gupta, Sandeep; Schoepfer, Alain M; Straumann, Alex; Safroneeva, Ekaterina; Grimm, Michael; Smith, Heather; Tompkins, Cindy-Ann; Woo, Amy; Peach, Robert; Frohna, Paul; Gujrathi, Sheila; Penenberg, Darryl N; Li, Caiyan; Opiteck, Gregory J; Olson, Allan; Aranda, Richard; ... (2019). RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. Gastroenterology, 156(3), 592-603.e10. Elsevier 10.1053/j.gastro.2018.10.051
Gastroenterology, vol. 156, no. 3, pp. 592-603.e10
Opis pliku :
application/pdf
Tytuł :
Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion?:An analysis of the AMPLE and ATTEST trials
Autorzy :
Buch, Maya H
Johnsen, Alyssa
Schiff, Michael
Pokaż więcej
Temat :
skin and connective tissue diseases
Infliximab
DNA/analysis
Antibodies, Monoclonal/therapeutic use
musculoskeletal diseases
Abatacept/therapeutic use
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Antirheumatic Agents/therapeutic use
Arthritis, Rheumatoid/drug therapy
Treatment Failure
immune system diseases
Methotrexate/therapeutic use
stomatognathic diseases
Humans
Źródło :
Buch, M H, Johnsen, A & Schiff, M 2019, ' Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials ', Clinical and Experimental Rheumatology, vol. 37, no. 1, pp. 127-132 .
Tytuł :
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Autorzy :
Sacco, Simona
Bendtsen, Lars
Ashina, Messoud
Reuter, Uwe
Terwindt, Gisela
Mitsikostas, Dimos-Dimitrios
Martelletti, Paolo
Pokaż więcej
Temat :
Antibodies, Monoclonal/therapeutic use
Fremanezumab
Antibodies, Monoclonal, Humanized
Migraine Disorders/drug therapy
Galcazenumab
Eptinezumab
Calcitonin Gene-Related Peptide Receptor Antagonists/therapeutic use
Chronic migraine
Prevention
Migraine
Consensus Article
Calcitonin gene-related peptide
Medicine
Systematic Review
Headache/drug therapy
Expert Testimony
Calcitonin Gene-Related Peptide/antagonists & inhibitors
Erenumab
Journal Article
Humans
Practice Guideline
Źródło :
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-33 (2019)
Sacco, S, Bendtsen, L, Ashina, M, Reuter, U, Terwindt, G, Mitsikostas, D-D & Martelletti, P 2019, ' European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention ', The Journal of Headache and Pain, vol. 20, 6 . https://doi.org/10.1186/s10194-018-0955-y
The Journal of Headache and Pain
Opis pliku :
application/pdf
Tytuł :
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
Autorzy :
De Benedetti, F.
Gattorno, M.
Anton, J.
Ben-Chetrit, E.
Frenkel, J.
Hoffman, H. M.
Kone-Paut, I.
Lachmann, H. J.
Ozen, S.
Simon, A.
Zeft, A.
Penades, I. Calvo
Moutschen, M.
Quartier, P.
Kasapcopur, O.
Shcherbina, A.
Hofer, M.
Hashkes, P. J.
Van der Hilst, Jeroen
Hara, R.
Bujan-Rivas, S.
Constantin, Tamas
Gul, A.
Livneh, A.
Brogan, P.
Cattalini, M.
Obici, L.
Lheritier, K.
Speziale, A.
Junge, G.
Pokaż więcej
Temat :
Double-Blind Method
Mevalonate Kinase Deficiency/drug therapy
Antibodies, Monoclonal/administration & dosage/adverse effects/therapeutic use
Young Adult
Médecine générale & interne [Sciences de la santé humaine]
Interleukin-1beta/antagonists & inhibitors
Injections, Subcutaneous
Familial Mediterranean Fever/drug therapy
Hereditary Autoinflammatory Diseases/drug therapy
Medicine(all)
Adolescent
General & internal medicine [Human health sciences]
Fever/drug therapy
Adult
Antibodies, Monoclonal/administration & dosage
Antibodies, Monoclonal/adverse effects
Antibodies, Monoclonal/therapeutic use
Child
Child, Preschool
Dose-Response Relationship, Drug
Female
Humans
Male
Źródło :
The New England journal of medicine, vol. 378, no. 20, pp. 1908-1919
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. New England Journal of Medicine, 378(20), 1908-1919., United States. (2018).
New England Journal of Medicine, 378(20), 1908. Massachussetts Medical Society
Opis pliku :
application/pdf; image/pdf
Tytuł :
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
Autorzy :
Apetoh, L.
Ladoire, S.
Coukos, G.
Ghiringhelli, F.
Pokaż więcej
Temat :
Antibodies, Monoclonal/therapeutic use
Antineoplastic Agents/therapeutic use
Combined Modality Therapy/methods
Humans
Immunotherapy/methods
Neoplasm Metastasis/immunology
Neoplasm Metastasis/prevention & control
Neoplasms/immunology
Neoplasms/therapy
Źródło :
Annals of Oncology, vol. 26, no. 9, pp. 1813-1823
Opis pliku :
application/pdf
Tytuł :
Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland.
Autorzy :
Mangana, Joanna
Cheng, Phil F.
Kaufmann, Corina
Amann, Valerie C.
Frauchiger, Anna L.
Stögner, Viola
Held, Ulrike
von Moos, Roger
Michielin, Olivier
Braun, Ralph P.
Levesque, Mitchell P.
Goldinger, Simone M.
Dummer, Reinhard
Pokaż więcej
Temat :
targeted therapy
ORIGINAL ARTICLES: Clinical research
overall survival data
Epidemiology, Biostatistics and Prevention Institute (EBPI)
Dermatology Clinic
610 Medicine & health
Antibodies, Monoclonal/therapeutic use
Cohort Studies
Humans
Immunotherapy/methods
Melanoma/drug therapy
Melanoma/pathology
Middle Aged
Retrospective Studies
Skin Neoplasms/drug therapy
Skin Neoplasms/pathology
Switzerland
melanoma
Clinic and Policlinic for Internal Medicine
Źródło :
Mangana, Joanna; Cheng, Phil F; Kaufmann, Corina; Amann, Valerie C; Frauchiger, Anna L; Stögner, Viola; Held, Ulrike; von Moos, Roger; Michielin, Olivier; Braun, Ralph P; Levesque, Mitchell P; Goldinger, Simone M; Dummer, Reinhard (2017). Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma research, 27(4):358-368.
Melanoma research, vol. 27, no. 4, pp. 358-368
Opis pliku :
application/pdf
Tytuł :
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis:1-year clinical outcomes from the DANBIO registry
Autorzy :
Glintborg, Bente
Sørensen, Inge Juul
Loft, Anne Gitte
Lindegaard, Hanne
Linauskas, Asta
Hendricks, Oliver
Hansen, Inger Marie Jensen
Jensen, Dorte Vendelbo
Manilo, Natalia
Espesen, Jakob
Klarlund, Mette
Grydehøj, Jolanta
Dieperink, Sabine Sparre
Kristensen, Salome
Olsen, Jimmi Sloth
Nordin, Henrik
Chrysidis, Stavros
Dalsgaard Pedersen, Dorte
Sørensen, Michael Veedfald
Andersen, Lis Smedegaard
Grøn, Kathrine Lederballe
Krogh, Niels Steen
Pedersen, Lars
Hetland, Merete Lund
Pokaż więcej
Temat :
Journal Article
Ankylosing Spondylitis
Rheumatoid arthritis
Anti-TNF
Outcomes research
Psoriatic arthritis
Humans
Middle Aged
Antibodies, Monoclonal/therapeutic use
Arthritis, Rheumatoid/drug therapy
Male
Treatment Outcome
Biosimilar Pharmaceuticals
Arthritis, Psoriatic/drug therapy
Spondylarthropathies/drug therapy
Infliximab
Denmark
Adult
Female
Registries
Aged
Antirheumatic Agents/therapeutic use
Drug Substitution
Źródło :
Glintborg, B, Sørensen, I J, Loft, A G, Lindegaard, H, Linauskas, A, Hendricks, O, Hansen, I M J, Jensen, D V, Manilo, N, Espesen, J, Klarlund, M, Grydehøj, J, Dieperink, S S, Kristensen, S, Olsen, J S, Nordin, H, Chrysidis, S, Dalsgaard Pedersen, D, Sørensen, M V, Andersen, L S, Grøn, K L, Krogh, N S, Pedersen, L, Hetland, M L & all departments of rheumatology in Denmark 2017, ' A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis : 1-year clinical outcomes from the DANBIO registry ', Annals of the Rheumatic Diseases, vol. 76, no. 8, pp. 1426-1431 . https://doi.org/10.1136/annrheumdis-2016-210742
Tytuł :
Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis:nationwide results from the DERMBIO registry
Autorzy :
Egeberg, A
Iversen, L.
Gniadecki, R.
Hvid, Lone
Dam, T N
Bryld, L E
Skov, L.
Pokaż więcej
Temat :
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal/therapeutic use
Comorbidity
Denmark
Dermatologic Agents/therapeutic use
Female
Humans
Male
Psoriasis/complications
Registries
Severity of Illness Index
Ustekinumab/therapeutic use
Źródło :
Egeberg, A, Iversen, L, Gniadecki, R, Hvid, L, Dam, T N, Bryld, L E & Skov, L 2017, ' Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis : nationwide results from the DERMBIO registry ', Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 7, pp. 1183–1187 . https://doi.org/10.1111/jdv.14200

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies